OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Haematological Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,293 reports · 123 co-occurring drugs

As of the last recalculation, Haematological Infection appears in 2,293 FAERS reports alongside 123 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 37.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Teduglutide5537.938.1
Posaconazole Delayed-Release4134.534.6
Anti-Thymocyte Globulin (Rabbit)2528.428.5
Thiotepa2927.928.0
Daptomycin2625.925.9
Posaconazole4123.323.4
Fludarabine Phosphate7818.618.6
Human Immunoglobulin G4118.318.4
Amphotericin B2316.816.9
Melphalan4016.216.3
Meropenem5415.615.6
Melphalan Hydrochloride4014.714.7
Mycophenilic Acid3113.813.8
Piperacillin Sodium,Tazobactam Sodium3712.912.9
Acalabrutinib1712.812.8
Valganciclovir Hydrochloride Powder,1612.012.0
Azacitidine For2311.611.6
Ocrelizumab7611.511.5
Everolimus Tablets2111.511.5
Cyclobenzaprine Hydrochloride1111.211.2
Eptinezumab-Jjmr1111.011.0
Ravulizumab1610.810.8
Mycophenolic Acid3610.410.4
Tacrolimus Ointment 0.1%13210.110.2
Tacrolimus Extended-Release Capsules13210.110.1
Cytarabine639.89.8
Valganciclovir199.29.2
Valganciclovir Hydrochloride199.29.2
Azacitidine288.78.7
Sodium Chloride738.68.6
0Xygen468.68.6
Oxygen468.68.6
Sodium Chloride Tablet688.68.6
Sodium Chloride Tablets688.68.6
Mycophenolate Mofetil1198.38.3
Mycophenolate Mofetil Hydrochloride1198.38.3
Oxybutynin Chloride88.38.3
Tacrolimus1358.38.3
Tiotropium Bromide Inhalation Spray108.18.1
Busulfan148.18.1
Ciclesonide128.08.0
Methocarbamol Tablets147.67.6
Adrenalinum347.57.5
Venetoclax497.47.4
Methocarbamol187.27.3
Terazosin Hydrochloride77.27.2
Ursosiol157.07.0
Lanreotide Acetate67.07.0
Prochlorperazine Maleate76.96.9
Benralizumab156.86.8
Metolazone86.56.5
Micafungin Sodium66.46.4
Fam-Trastuzumab Deruxtecan-Nxki76.36.3
Ursodiol156.36.3
Alpelisib66.36.3
Brentuximab Vedotin76.26.2
Oxycodone And Acetaminophen Tablets86.16.1
Cetirizine Hcl66.06.0
Treprostinil785.85.8
Lamotirigine455.85.8
Lamotrigine Extended-Release455.85.8
Lamotrigine Chewable Dispersible455.85.8
Piperacillin And Tazobactam85.75.7
Cladribine65.75.7
Atovaquone55.65.7
Epinephrine405.65.6
Axicabtagene Ciloleucel65.55.5
Tafamidis75.45.4
Tocilizumab665.45.4
Oxcarbazepine195.35.3
Sildenafil335.25.2
Olaparib125.25.2
Macitentan395.25.2
Vismodegib55.15.1
Cyclophosphamide Injection, Solution945.05.0
Cyclophosphamide945.05.0
Cyclophosphamide For Injection945.05.0
Irinotecan Hydrochloride75.05.0
Nintedanib174.95.0
Amikacin94.84.8
Abiraterone74.74.7
Polatuzumab Vedotin54.74.7
Diroximel Fumarate64.64.6
Risankizumab-Rzaa404.54.5
Pegaspargase64.54.5
Lacosamide184.44.4
Empagliflozin324.44.4
Selinexor44.24.2
Vedolizumab394.24.2
Ofatumumab154.14.1
Remdesivir64.14.1
Fremanezumab-Vfrm54.04.0
Upadacitinib353.93.9
Naltrexone133.83.8
Ruxolitinib303.83.8
Ifosfamide93.83.8
Erlotinib43.83.8
Durvalumab83.63.6
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate163.53.5
Budesonide, Glycopyrrolate, And Formoterol Fumarate43.53.5
Rifaximin83.53.5
Relugolix93.53.5
Deferasirox103.43.4
Vibegron33.43.4
Daratumumab143.23.2
Emicizumab42.92.9
Pomalidomide322.92.9
Brexpiprazole52.72.7
Abemaciclib62.72.7
Osimertinib92.62.6
Dasatinib102.42.4
Sarilumab72.42.4
Lenalidomide1082.42.4
Apalutamide32.32.3
Pimavanserin Tartrate142.32.3
Patiromer32.02.0
Abaloparatide61.91.9
Pirfenidone81.81.8
Bimekizumab41.71.7
Guselkumab61.51.5
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride51.51.5
Voxelotor31.21.2
Dupilumab611.21.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.